Holen Sie sich die Stockscreener-App
17.19
0.12%
-0.02
Handel nachbörslich:
17.21
0.02
+0.12%
Schlusskurs vom Vortag:
$17.21
Offen:
$17.23
24-Stunden-Volumen:
111.36K
Relative Volume:
1.02
Marktkapitalisierung:
$522.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.32%
1M Leistung:
-2.77%
6M Leistung:
+2.26%
1J Leistung:
+41.25%
1-Tages-Spanne:
$17.17
$17.46
1-Wochen-Bereich:
$17.00
$17.89
52-Wochen-Spanne:
$12.12
$18.46
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Firmenname
Abrdn Life Sciences Investors
Sektor
Branche
Telefon
-
Adresse
-
Compare HQL vs DNP, UTG, ADX, UTF, GDV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
17.19 | 523.32M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
10.82 | 4.08B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
42.55 | 3.85B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
25.02 | 3.05B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
26.98 | 3.01B | 0 | 0 | 0 | 0.00 |
GDV
Gabelli Dividend Income Trust
|
29.08 | 2.54B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
abrdn Life Sciences Investors (HQL) Edges Higher as Sector Rotations Lift Healthcare-Focused CEFEquity Put Call - Newser
abrdn Life Sciences Investors (HQL) Edges Higher, Approaching ResistancePrice Momentum Stocks - Newser
abrdn Life Sciences Investors Q1 2026 Commentary - Seeking Alpha
HQL: Attractive Outlook With Growth Of GLP-1 Market (NYSE:HQL) - Seeking Alpha
Abrdn Healthcare Opportunities Fund Q1 2026 Commentary (NYSE:THQ) - Seeking Alpha
Abrdn Healthcare Investors Q1 2026 Commentary (NYSE:HQH) - Seeking Alpha
abrdn Healthcare Investors (HQH) Declares $0.61 Quarterly Divide - GuruFocus
Abrdn Life Sciences Investors To Go Ex-Dividend On May 21st, 2026 With 0.56 USD Dividend Per Share - Moomoo
HQL (abrdn Life) life sciences investment trust holds quarterly distribution amid biotech sector volatility.Profit Guidance - Newser
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Moomoo
THQ (abrdn) Healthcare Opportunities Fund evaluates portfolio positioning as healthcare sector conditions shift.Trending Entry Points - Newser
The numbers behind abrdn (HQH) stock nobody talks about (Institutional Selling) 2026-05-08Reward Analysis - Newser
abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week HighTime to Buy? - MarketBeat
abrdn Life Sciences Investors $HQL Shares Sold by Wolverine Asset Management LLC - MarketBeat
Wolverine Asset Management LLC Makes New $2.78 Million Investment in abrdn Healthcare Investors $HQH - MarketBeat
HQL abrdn Life quarterly earnings metrics remain undisclosed as investors seek updates on its life sciences portfolio performance.Financial Summary - Newser
abrdn Healthcare Investors (NYSE:HQH) Sees Large Decrease in Short Interest - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Stock Price Crosses Above 50 Day Moving AverageShould You Sell? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Down 38.8% in April - MarketBeat
Is abrdn (HQH) stock appealing to investors right now |Brand Strength - newser.com
abrdn Life (HQL) Stock Low Risk Entry (Slow Drop) 2026-04-20Hot Momentum - Cổng thông tin điện tử Tỉnh Sơn La
abrdn Life Sciences Investors (NYSE:HQL) Sets New 1-Year HighHere's Why - MarketBeat
Thank You, Seniors. Healthcare Spending Is Fueling Economic And Job GrowthTHQ - Seeking Alpha
abrdn Healthcare Investors (NYSE:HQH) Short Interest Update - MarketBeat
abrdn Life (HQL) Stock: Reversal Setup? (Trend Strengthens) 2026-04-18Fibonacci Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Shaker Financial Services LLC Has $1.94 Million Holdings in abrdn Life Sciences Investors $HQL - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Up 22.2% in March - MarketBeat
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ADVFN
Returns Recap: Will Abrdn Life Sciences Investors outperform tech stocks2026 Update & Daily Growth Stock Tips - baoquankhu1.vn
Hedge Fund Bets: Should I hold or sell Abrdn Healthcare Investors now2026 Key Highlights & Expert Verified Movement Alerts - baoquankhu1.vn
Risks Report: Will Abrdn Life Sciences Investors stock recover after earnings2026 Opening Moves & Safe Entry Zone Identification - baoquankhu1.vn
Aug Closing: Will MREO announce a stock split2026 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Bond Watch: Will Abrdn Life Sciences Investors benefit from rising consumer demandWeekly Risk Summary & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Trustee elections ahead for abrdn healthcare funds (NYSE: HQH) - Stock Titan
Will abrdn Life (HQL) Stock Outperform Peers | Price at $17.00, Up 0.95%Linear Regression - Newser
HQH Stock Analysis: abrdn Healthcare Investors 0.38% Dip at $18.21 Performance Outlook - Xã Thanh Hà
Options Flow: Is Abrdn Life Sciences Investors vulnerable to short sellersMarket Growth Review & Long Hold Capital Preservation Tips - baoquankhu1.vn
Tech Rally: Will Abrdn Life Sciences Investors benefit from geopolitical trendsRate Hike & Weekly Top Performers Watchlists - baoquankhu1.vn
Price Action: Can Abrdn Life Sciences Investors sustain earnings growth2026 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Is abrdn Life (HQL) Stock a Safe Investment | Price at $17.22, Up 0.34%Stock Analysis - Newser
Stock List: Research Stocks from Around the World - GuruFocus
abrdn Life Sciences Investors (NYSE:HQL) Sees Large Increase in Short Interest - MarketBeat
Aug Weekly: Can Abrdn Life Sciences Investors sustain earnings growth2026 Trade Ideas & Safe Capital Growth Plans - baoquankhu1.vn
THW: A Global Healthcare Fund With 11% Yield But Overpays The Distribution (NYSE:THW) - Seeking Alpha
abrdn Healthcare Investors (NYSE:HQH) Stock Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Earnings Report: Is Abrdn Life Sciences Investors benefiting from innovation trends2026 Support & Resistance & Verified Short-Term Plans - baoquankhu1.vn
Finanzdaten der Abrdn Life Sciences Investors-Aktie (HQL)
Es liegen keine Finanzdaten für Abrdn Life Sciences Investors (HQL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):